A randomized double blind study to compare the effectiveness and safety of an oral drug plus supportive care vs supportive care as maintenance therapy in patients with acute myeloid leukemia in complete remission
To determine the safety and effectiveness of oral azacitidine plus best supportive care vs supportive care only in patient with acue myeloid leukemia in complete remission
Primary Sponsor: Celgene
Prinicipal Investigator: Dr. Imad Tabbara
Are you interested in more information on this clinical trial?